HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Berthier-Vergnes Selected Research

O Berthier-Vergnes Research Topics

Disease

7Melanoma (Melanoma, Malignant)
04/2017 - 10/2000
1Carcinoma (Carcinomatosis)
01/2017
1Skin Neoplasms (Skin Cancer)
01/2017
1Necrosis
02/2004
1Inflammation (Inflammations)
02/2004
1Neoplasms (Cancer)
08/2001

Drug/Important Bio-Agent (IBA)

3TetraspaninsIBA
04/2017 - 01/2011
3Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2004
2Messenger RNA (mRNA)IBA
01/2011 - 08/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2004 - 12/2001
2CollagenIBA
10/2001 - 10/2000
1matrigelIBA
04/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017
1VemurafenibIBA
01/2017
1OligonucleotidesIBA
01/2011
1CytokinesIBA
02/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2004
1Vascular Endothelial Growth Factor BIBA
02/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2004
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2001
1Transforming Growth Factor beta1 (TGF beta 1)IBA
12/2001
1progelatinaseIBA
10/2001
1EnzymesIBA
10/2001
1Aprotinin (Trasylol)FDA Link
10/2001
1batimastat (BB 94)IBA
10/2001
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
10/2001
1Collagen Type I (Type I Collagen)IBA
10/2001
1FurinIBA
10/2001
1Matrix Metalloproteinase 13IBA
10/2001
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
08/2001
1Actins (F Actin)IBA
08/2001
1Complementary DNA (cDNA)IBA
08/2001
1RNA (Ribonucleic Acid)IBA
08/2001

Therapy/Procedure

1Therapeutics
01/2017